Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.38 |
| ▸ | FYN | P06241 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | AHR | P35869 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25112815 | 0.92 | KDM4E (0.37) | KDM4EATML3MBTL1CYP1A2ERBB2 | |
| SCHEMBL25112824 | 0.91 | KDM4E (0.36) | KDM4EATML3MBTL1CYP1A2ERBB2 | |
| SCHEMBL16271350 | 0.90 | KDM4E (0.38) | KDM4EATML3MBTL1CYP1A2ERBB2 | |
| SCHEMBL15835105 | 0.89 | KDM4E (0.38) | KDM4EATML3MBTL1CYP1A2ERBB2 | |
| SCHEMBL15835087 | 0.87 | KDM4E (0.41) | KDM4EATML3MBTL1SIGMAR1 | |
| SCHEMBL18416110 | 0.87 | KDM4E (0.41) | KDM4EATML3MBTL1CYP1A2ERBB2 | |
| SCHEMBL24657121 | 0.87 | KDM4E (0.45) | KDM4EATML3MBTL1CYP1A2ERBB2 | |
| SCHEMBL16271369 | 0.87 | KDM4E (0.41) | KDM4EATML3MBTL1CYP1A2ERBB2 | |
| SCHEMBL15731028 | 0.87 | KDM4E (0.47) | KDM4EATML3MBTL1CYP1A2ERBB2 | |
| SCHEMBL28522567 | 0.86 | KDM4E (0.50) | KDM4EATML3MBTL1CYP1A2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230085328-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230085328-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | L1CAM, PIEZO1, LEF1 | KDM4E 1371/4885ATM 2202/4885L3MBTL1 713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.